241 related articles for article (PubMed ID: 33210582)
1. Cellular and Molecular Targeted Drug Delivery: Nanochemistry in Medical Theranostics.
Yadollahpour A
Curr Top Med Chem; 2020; 20(27):2425-2426. PubMed ID: 33210582
[No Abstract] [Full Text] [Related]
2. Zeolites for theranostic applications.
Khodadadi Yazdi M; Zarrintaj P; Hosseiniamoli H; Mashhadzadeh AH; Saeb MR; Ramsey JD; Ganjali MR; Mozafari M
J Mater Chem B; 2020 Jul; 8(28):5992-6012. PubMed ID: 32602516
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology Assisted Chemotherapy for Targeted Cancer Treatment: Recent Advances and Clinical Perspectives.
Lan HR; Wu ZQ; Zhang LH; Jin KT; Wang SB
Curr Top Med Chem; 2020; 20(27):2442-2458. PubMed ID: 32703133
[TBL] [Abstract][Full Text] [Related]
5. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
6. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
[TBL] [Abstract][Full Text] [Related]
7. Bioinspired approaches for cancer nanotheranostics.
Evangelopoulos M; Tasciotti E
Nanomedicine (Lond); 2017 Jan; 12(1):5-7. PubMed ID: 27876435
[No Abstract] [Full Text] [Related]
8. A Mini-Review on Nano Technology in the Tumour Targeting Strategies: Drug Delivery to Cancer Cells.
Kaur L; Sohal HS; Kaur M; Malhi DS; Garg S
Anticancer Agents Med Chem; 2020; 20(17):2012-2024. PubMed ID: 32753024
[TBL] [Abstract][Full Text] [Related]
9. Transferrin-Conjugated Nanocarriers as Active-Targeted Drug Delivery Platforms for Cancer Therapy.
Nogueira-Librelotto DR; Codevilla CF; Farooqi A; Rolim CM
Curr Pharm Des; 2017; 23(3):454-466. PubMed ID: 27784246
[TBL] [Abstract][Full Text] [Related]
10. Development and Advances of Drugs for Cancer Theranostics.
Feng LS
Curr Top Med Chem; 2020; 20(16):1440. PubMed ID: 32705971
[No Abstract] [Full Text] [Related]
11. Encapsulation for Cancer Therapy.
Montané X; Bajek A; Roszkowski K; Montornés JM; Giamberini M; Roszkowski S; Kowalczyk O; Garcia-Valls R; Tylkowski B
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244513
[TBL] [Abstract][Full Text] [Related]
12. Exploring Factors for the Design of Nanoparticles as Drug Delivery Vectors.
Castillo PM; Jimenez-Ruiz A; Carnerero JM; Prado-Gotor R
Chemphyschem; 2018 Nov; 19(21):2810-2828. PubMed ID: 30102468
[TBL] [Abstract][Full Text] [Related]
13. Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics.
Rahimkhoei V; Alzaidy AH; Abed MJ; Rashki S; Salavati-Niasari M
Adv Colloid Interface Sci; 2024 Jul; 329():103204. PubMed ID: 38797070
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nanoparticles in Precise Cancer Treatment: Considerations in Design and Functionalization of Nanocarriers.
Lu L; Kang S; Sun C; Sun C; Guo Z; Li J; Zhang T; Luo X; Liu B
Curr Top Med Chem; 2020; 20(27):2427-2441. PubMed ID: 32842941
[TBL] [Abstract][Full Text] [Related]
15. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
Patra CR
Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
[No Abstract] [Full Text] [Related]
16. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
17. Recent Progress of Nano-drug Delivery System for Liver Cancer Treatment.
Zhou F; Teng F; Deng P; Meng N; Song Z; Feng R
Anticancer Agents Med Chem; 2018 Feb; 17(14):1884-1897. PubMed ID: 28707574
[TBL] [Abstract][Full Text] [Related]
18. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy.
Fu Z; Xiang J
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266216
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
Lim EK; Chung BH; Chung SJ
Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
